Two Israeli medical cannabis companies announced entering a strategic partnership to co-found development and clinical validation of a range of cannabis-based ADHD products.

The two companies, Yom Chai and Kaneh-B, will conduct joint scientific trials in Israel utilizing various cannabinoids to bridge the gap between patients and doctors to bring scientifically-validated products to market.

Scot Albert, CEO of Yom Chai said, “We are excited to be working with Ofer Segal CEO and Yahav Blaicher Co-Founder of Kaneh-B to formulate, manufacture, and distribute world class cannabis-based products to the international marketplace”.

Click here to read the complete article

Mordechai Sones ~ IsraelNationalNews.com

Recent News Articles

Sunday August 18

Weed From Well-Known Lifestyle Brands Is Next Stage of Legal Cannabis

in Shopping

by Bruce Kennedy - Editor in Chief

In July, to commemorate their first anniversary, a Colorado couple in their 30s wanted a…

162 hits

Monday August 19

Top Trending Cannabis Strains for College-Aged Consumers

in Cannabis News

by Bruce Kennedy - Editor in Chief

In some places, the legal age to consume cannabis is 18 with a medical card;…

611 hits

Monday August 19

‘The system is swamped.’ Canada can’t keep up with requests to study cannabis

in Medical News

by Bruce Kennedy - Editor in Chief

The Canadian government is scrambling to respond to a glut of license applications for cannabis…

333 hits

Tuesday August 20

Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis?

in Science

by Bruce Kennedy - Editor in Chief

Arizona-based researcher Dr. Sue Sisley is spearheading an extraordinary lawsuit against the U.S. Drug Enforcement…

167 hits

Tuesday August 20

California’s legal marijuana will outsell the black market in 5 years, forecast says

in U.S. News

by Bruce Kennedy - Editor in Chief

California’s black market for marijuana still rakes in more cash than the state’s legal cannabis…

172 hits